Greenwood Village, CO – April 10th, 2023 – Caring Closures (CCI), a company transforming public health and consumer product safety with a long overdue update to access control technology in caps and closures, today announced its President and CEO, Milton Cohen, will be presenting at two upcoming investor conferences.
Mr. Cohen will be presenting at the Landmark Capital & Tech Coast Angels Forum on April 11th, 2023. Landmark Capital is hosting this event in conjunction with Tech Coast Angels, reaching over 700 fund managers, former executives of major corporations, entrepreneurs, and family offices. To register for the event please contact email@example.com.
Mr. Cohen will also be presenting at the Ivy Family Office Network (IVYFON) New York Forum on April 18th, 2023. IVYFON has been the leading peer-to-peer family office network since the early 2000s. More than 50,000 investors, family offices and asset allocators have attended IVYFON events. To register for the event please visit https://ivyfon.com/apr18-19forum/registration.html.
CCI’s award-winning Safe Rx® locking prescription vial (LPV®) line is sold into multiple healthcare and pharmacy verticals for use in medication safety and pharmacy dispensing. Safe Rx LPVs prevent pilfering (sneaking pills), the #1 source for teen drug abuse in the U.S. and a leading source of diversion in other household and institutional settings.
LPV dispensing is clinically proven to reduce the top three barriers to patient enrollment in medication-assisted treatment (MAT) programs, which generate significant reductions in acute care utilization with accompanying cost savings for payors and providers. Several additional trials underway are testing LPV efficacy in controlled substance dispensing, with results expected in 2023 and 2024.
The Company is raising capital to support 2023 growth in payor coverage for MAT dispensing, and to develop broader reimbursement coverage for controlled substance dispensing in 2024.
About Caring Closures International
Caring Closures International (CCI) is transforming public health and consumer product safety with a long overdue update to access control technology across the global 14-billion-unit cap and closure market. Its Safe Rx® branded locking prescription vials (LPVs®) are used in multiple healthcare and pharmacy verticals. CCI’s patented cap & closure technology is expected to replace a broad cross section of child-resistant consumer product packaging, delivering a proven intervention in multiple epidemic scale public health crises. For more information, please visit www.safe-rx.com.